Upcoming

Tuesday and Wednesday, July 12-13, 2022 Conference: MaidStone Life Sciences and William Blair & Company will host the 12th Annual Cancer Immunotherapy Conference. This unique, two-day conference unites founding visionary researchers, clinicians, business leaders, key investors, and other stakeholders to engage in discussions, exchange information, highlight opportunities, and showcase leading companies in the field of cancer immunotherapy.

The conference format is designed to foster networking, knowledge sharing and learning in an interactive environment.

For more information about the conference >>

Profile

As a strategic advisor and partner, we provide a full range of services to help our clients increase visibility, unlock stakeholder value and access resources to grow their business.

A boutique management and strategy consulting firm focusing on both public and private companies in the life sciences industry.

We have an extensive network of venture capitalists, institutional investors, high net worth individuals, sell side research analysts, investment bankers, key opinion leaders and other sources of capital.

Headquartered near dense populations of life science companies, world’s financial capital (NYC), National Institutes of Health (NIH) and the FDA

As a strategic advisor and partner, clients depend on our objective, third-party perspectives and additional expertise to help solve many corporate challenges.
As a strategic advisor and partner, clients depend on our objective, third-party perspectives and additional expertise to help solve many corporate challenges
  • Objective Research Reports and Industry White Papers
  • We author objective comprehensive research reports on client companies including detailed overview of the lead drug candidates, mechanism of action, clinical data, competitive landscape and market potential.
  • Provide research reporting for companies specializing in pharmaceutical and biotechnology discovery and development, drug delivery, medical technology, and diagnostics. We research fundamentals, corporate and scientific milestones, to produce thoughtful, objective and comprehensive evaluations of each company’s investment proposition. We stay up to date and communicate the latest developments in each client’s domain.
  • Unique Access to Key Opinion Leaders